One of the most advanced cancer centers in Colombia, developed and managed in partnership with UPMC, is preparing to open near Bucaramanga to provide care close to home for both children and adults, according to a press release from UPMC.
The new Oncology Institute is part of a recently opened 870-bed hospital owned by UPMC’s long-time partner Fundación Cardiovascular de Colombia (FCV), a provider of cardiac care.
The 200-bed Oncology Institute at the new Hospital Internacional de Colombia (HIC), located in the town of Piedecuesta, will provide state-of-the-art medical and radiation oncology treatments to patients who previously traveled hundreds of miles to receive such care in other regions. Colombia alone will see nearly 80,000 new cases of cancer this year, a number expected to grow to 113,000 cases annually over the next 10 years.
Financed and operated by FCV, the Oncology Institute includes chemotherapy and highly specialized radiotherapy services, with future plans for a bone marrow transplant unit. Additionally, the institute offers a palliative care program, counseling and nutrition services, and a pain management program, the press release notes.
The center houses one of South America’s first Varian TrueBeam STx linear accelerators, which delivers high-dose radiation to treat the most challenging tumors, including breast, lung, prostate and head and neck cancers. The goal is to minimize disabling side effects for patients while maximizing survival, as told by the press release.